Testing should only be performed on individuals meeting Centers for Disease Control and Prevention (CDC) clinical criteria for Zika virus (eg, clinical signs and symptoms associated with Zika virus infection) and/or CDC epidemiological criteria for Zika virus (eg, history of residence in or travel to a geographic region with active Zika transmission at the time of travel, or other epidemiological criteria for which Zika virus testing may be indicated).
- Patient Preparation
- Serum Separator Tube (SST).
- Specimen Preparation
- Separate from cells. Transfer 2 mL serum to a sterile container. (Min: 1 mL)
- Storage/Transport Temperature
- Unacceptable Conditions
- Urine (refer to Zika Virus by PCR, Urine, ARUP test code 2014069).
- Specimen source required.
- Ambient: Unacceptable; Refrigerated: 5 days; Frozen: 6 weeks
A positive RT-PCR result confirms Zika virus infection, and no additional testing is indicated. When test results are negative, the serum should be tested as outlined in the current CDC-issued algorithm (http://www.cdc.gov/zika/laboratories/lab-guidance.html).
If serologic testing is needed as a follow-up to PCR, contact ARUP client services to order Zika Virus IgM Antibody Capture (MAC), by ELISA (ARUP test code 2013942). Additional charges apply.
The Zika Virus by PCR test is for in vitro diagnostic use under the FDA Emergency Use Authorization (EUA). This test has not been FDA cleared or approved. In compliance with this authorization, please visit https://aruplab.com/zika for more information and to access the applicable information sheets.
|Component Test Code*||Component Chart Name||LOINC|
|2014066||Zika Virus, Blood, Source||31208-2|
|2014067||Zika Virus by PCR, Blood||79190-5|